NatureCell Co 007390.KQ · KRW

Its shares trade on KOSDAQ under the ticker 007390.KQ. It has been listed since 30 November 1992. In the fiscal year to 31 December 2025, it reported revenue of ₩20.73bn and a net loss of ₩2.84bn. At that date it held total assets of ₩74.73bn and shareholders' equity of ₩63.03bn.

NATURECELL Co., Ltd. engages in the research and development of stem cells. The company is headquartered in Seoul, Seoul. The firm operates its business through three segments. The Stem Cell Business segment is engaged in the development of stem cell therapeutics, the manufacture of stem cell culture media, the development and sale of stem cell culture cosmetics, and the provision of blood cell storage services, among others. The Food Business segment is engaged in the manufacture and sale of fruit beverages including tomato juice, peach juice and others, canned beverages such as sikhye, fruit concentrates and others, as well as fermentation and health functional foods. The Hygiene Business segment is engaged in the manufacture and sale of health hygiene products such as masks, disinfectants, wipes, and others.

Figures and description from our data supplier, not checked against the company's own report.

• Dae Jung ByunPresident, Chief Executive Officer, Director, since 2023
• Nam Su KimAssistant Managing Director, since 2010
• Yong Geun ChoiInternal Auditor
• Byeong Ha JangInternal Auditor
• Seung Min KimDirector
• Sang Cheol ParkDirector

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.